ema prac naion semaglutide very rare side effect june 2025 A potentially blinding condition is a of the GLP-1 receptor agonist (Ozempic, Wegovy, Rybelsus), the European Medicines Agency (EMA) concluded. https://www.medpagetoday.com/ophthalmology/generalophthalmology/115938?trw=no Does Ozempic Cause Blindness? [2026
Description
Typical experiences include reduced hunger, enhanced satiety, decreased craving for calorie-dense foods, and increased energy for daily activities
Inform your dentist about all medications, including semaglutide
The 2025 Kokkorakis pharmacology review framed both compounds within the emerging-obesity-pharmacotherapy landscape (PMID 39952695)
This test reveals whether you're a strong GLP-1 responder or whether dual-therapy options might accelerate your results
